In type II polyketide
synthases (PKSs), which typically biosynthesize
several antibiotic and antitumor compounds, the substrate is a growing
polyketide chain, shuttled between individual PKS enzymes, while covalently
tethered to an acyl carrier protein (ACP): this requires the ACP interacting
with a series of different enzymes in succession. During biosynthesis
of the antibiotic actinorhodin, produced by
Streptomyces
coelicolor
, one such key binding event is between
an ACP carrying a 16-carbon octaketide chain (
act
ACP) and a ketoreductase (
act
KR). Once the octaketide
is bound inside
act
KR, it is likely cyclized between
C7 and C12 and regioselective reduction of the ketone at C9 occurs:
how these elegant chemical and conformational changes are controlled
is not yet known. Here, we perform protein–protein docking,
protein NMR, and extensive molecular dynamics simulations to reveal
a probable mode of association between
act
ACP and
act
KR; we obtain and analyze a detailed model of the C7–C12-cyclized
octaketide within the
act
KR active site; and we confirm
this model through multiscale (QM/MM) reaction simulations of the
key ketoreduction step. Molecular dynamics simulations show that the
most thermodynamically stable cyclized octaketide isomer (7
R
,12
R
) also gives rise to the most reaction
competent conformations for ketoreduction. Subsequent reaction simulations
show that ketoreduction is stereoselective as well as regioselective,
resulting in an
S
-alcohol. Our simulations further
indicate several conserved residues that may be involved in selectivity
of C7-12 cyclization and C9 ketoreduction. Detailed insights obtained
on ACP-based substrate presentation in type II PKSs can help design
ACP-ketoreductase systems with altered regio- or stereoselectivity.